Judge Closes Merck Derivative Suit Over Vioxx

Law360, New York (June 23, 2008, 12:00 AM EDT) -- A New Jersey federal judge has closed a derivative suit filed against Merck & Co. Inc. and its directors for allegedly ignoring health risks associated with painkiller Vioxx after once again denying shareholder plaintiffs' request to amend their complaint against the drugmaker.

U.S. District Judge Stanley R. Chesler of the District of New Jersey ruled on June 17 that proposed amendments by the shareholders would not make the case sound enough to move forward.

The plaintiffs wanted to add allegations that Merck's board of directors had...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.